Home page

Three experts of IP & Technology Transfer in the forefront medical field, such as regenerative medicine are invited from US. What are challenges and problems typical in this field? What’s the strategy of prosecution and commercialization in this field? Speech and discussion are expected.

Program
13:00-13:10 Opening remarks; Toshiaki Makabe, Vice president of Keio
13:10-13:20 Guest speech; Takashi Yanagi, Director of research environment / industry collaboration division of MEXT
13:20-13:25 Sponsor speech; Kenichi Hatori, Director of IP Center of Keio
13:25-13:35 IP Center Award -Keio internal award-
13:35-14:50 Speech of three experts from US ;

1. Dr. Michal Preminger; Executive Director, Harvard University Office of Technology Development
2. Dr. Benjamin Chu; Technology Transfer and Business Development Officer, University of California, Los Angeles
3. Dr. Andrew T. Serafini; Partner of Fenwick & West LLP

14:50-15:00 Break
15:00-17:00 Panel discussion

Panelist;

* Dr. Michal Preminger; Executive Director, Harvard University Office of Technology Development
* Dr. Benjamin Chu; Technology Transfer and Business Development Officer, University of California, Los Angeles
* Dr. Andrew T. Serafini; Partner of Fenwick & West LLP
* Mr. Mitsuomi Shirahashi, Director of IP & Legal department, iPS Academia Japan

Coordinator; Kenichi Hatori, Director of IP Center of Keio
17:00 Closing

Associated websites:

• Link to event